The methanolic extract of Garcinia atroviridis (MeGa) reduces body weight and food intake, and improves lipid profiles by altering the lipid metabolism: a rat model

Garcinia species are widely used for their slimming effects via increased fat burning and suppression of satiety. However, scientific evidence for the biological effects of Garcinia atroviridis (GA) is lacking. We investigated the phytochemical composition, safety profiles, and antioxidant and antiobesity effects of methanolic extracts of Garcinia atroviridis (MeGa) in obese female rats. Repeated dose toxicity studies were conducted according to the OECD guidelines. Upon sacrifice, haematological, biochemical, lipid profile, and serum-based metabolomics analyses were performed to evaluate metabolic expression changes and their related pathways. MeGa contains several phytochemical groups and GA fruit acids. MeGa was found to be nontoxic in both male and female rats with an oral lethal dose (LD50) of 2000 mg/kg. After 9 weeks of treatment, MeGa-treated obese rats had lower weight gain and better lipid profiles (cholesterol and triglyceride), which correlated with the altered metabolic pathways involved in the metabolism of lipid (glycerophospholipid) and biosynthesis of unsaturated fatty acid. In addition, MeGa caused differential metabolism pathways of arachidonic acid and tryptophan that affect the inflammatory response and suppression of appetite. We concluded that MeGa is safe, and its slimming effects are due to the differential metabolism of lipids.

___

  • Abdul Hisam EE, 2018, TURK J BIOL, V42, P33, DOI 10.3906/biy-1708-23
  • Abdullah AR, 2013, UJAS, V1, P95 .
  • Abu Bakar MH, 2015, MOL BIOSYST, V11, P1742, DOI 10.1039/c5mb00158g
  • Alias N., 2017, AOWMC, V6, P122 .
  • Alsarhan A, 2014, J BASIC APP SCI, V10, P149, DOI DOI 10.6000/1927-5129.2014.10.20
  • Amran AA, 2009, SINGAP MED J, V50, P295 .
  • Chen HH, 2015, INT J OBESITY, V39, P1241, DOI 10.1038/ijo.2015.65
  • Chuah LO, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/751658
  • Chuah LO, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/197920
  • Cirulli ET, 2019, CELL METAB, V29, P488, DOI 10.1016/j.cmet.2018.09.022
  • Crescioli G, 2018, INTERN EMERG MED, V13, P857, DOI 10.1007/s11739-018-1880-4
  • Du GX, 2015, FOOD SCI TECHNOL RES, V21, P835, DOI 10.3136/fstr.21.835
  • Hamidon H, 2017, MARMARA PHARM J, V21, P38, DOI 10.12991/marupj.259879
  • Han J, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0208-5
  • Han NN, 2016, PHYTOTHER RES, V30, P1316, DOI 10.1002/ptr.5630
  • Harborne J.B., 1998, PHYTOCHEMICAL METHOD
  • Keranen AM, 2009, PREV MED, V49, P32, DOI 10.1016/j.ypmed.2009.04.011
  • Kim HJ, 2011, J PROTEOME RES, V10, P722, DOI 10.1021/pr100892r
  • Kokate C.K, 2005, PRACTICAL PHARMACOGN, V5th
  • Kothadia Jiten P, 2018, Case Reports Hepatol, V2018, P6483605, DOI 10.1155/2018/6483605
  • Leonhardt M, 2001, PHYSIOL BEHAV, V74, P191, DOI 10.1016/S0031-9384(01)00547-9
  • Li LL, 2017, CELL PHYSIOL BIOCHEM, V43, P812, DOI 10.1159/000481564
  • Lumbantobing CJRE, 2017, AM SCI RES J ENG TEC, V34
  • Mackeen MM, 2000, J ETHNOPHARMACOL, V72, P395, DOI 10.1016/S0378-8741(00)00245-2
  • Nursakinah I, 2012, Malays J Nutr, V18, P363
  • Pangsuban S, 2009, TROP LIFE SCI RES, V20, P89
  • Park S, 2015, MOL CELLS, V38, P587, DOI 10.14348/molcells.2015.0126
  • Peng ML, 2018, ANIMAL, V12, P774, DOI 10.1017/S175173111700221X
  • Rittirut W., 2006, WALAILAK J SCI TECH, V3, P13
  • Shahid Chatha SA, 2014, J FOOD PROCESS TECHN, V5, P298, DOI DOI 10.4172/2157-7110.1000298
  • Soeliman FA, 2014, J RES MED SCI, V19, P268
  • Tarasenko TN, 2018, MOL GENET METAB, V125, P144, DOI 10.1016/j.ymgme.2018.06.012
  • Thibault L, 2013, ANIMAL MODELS FOR THE STUDY OF HUMAN DISEASE, P277, DOI 10.1016/B978-0-12-415894-8.00013-0
  • Xie BG, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/805683
  • Yang HS, 2011, MOLECULES, V16, P3444, DOI 10.3390/molecules16043444
  • Yapwattanaphun C, 2002, ACTA HORTIC, P563, DOI 10.17660/ActaHortic.2002.575.66